Published in Cornea on November 01, 1995
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2007) 1.29
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model. Int J Ophthalmol (2012) 0.83
Clinical correlates of common corneal neovascular diseases: a literature review. Int J Ophthalmol (2015) 0.82
Effect of Surgical Technique on Corneal Implant Performance. Transl Vis Sci Technol (2014) 0.81
Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol (2012) 0.81
KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization. Mol Vis (2011) 0.80
Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization. PLoS One (2014) 0.78
Sodium hyaluronate eye drops treatment for superficial corneal abrasion caused by mechanical damage: a randomized clinical trial in the People's Republic of China. Drug Des Devel Ther (2015) 0.77
[Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)]. Ophthalmologe (2014) 0.77
Graft failure: II. Ocular surface complications. Int Ophthalmol (2008) 0.76
Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells. Invest Ophthalmol Vis Sci (2014) 0.75
Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC Biotechnol (2014) 0.75
Role of Frequency Doubled Nd: Yag Laser in Treatment of Corneal Neovascularisation. J Clin Diagn Res (2016) 0.75
Contact Lens-related Complications: A Review. J Ophthalmic Vis Res (2017) 0.75
Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1976) 3.98
Structural studies on the type-specific antigens and lipids of the mycobacterium avium. Mycobacterium intracellulare. Mycobacterium scrofulaceum serocomplex. Mycobacterium intracellulare serotype 9. J Biol Chem (1979) 3.00
Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea (2000) 2.85
The indications for and outcome in pediatric keratoplasty. A multicenter study. Ophthalmology (1995) 2.41
Identification of atypical mycobacteria by thin-layer chromatography of their surface antigens. J Clin Microbiol (1978) 2.40
Mycobacterial lipids: selected topics. Bacteriol Rev (1972) 2.35
Phagocyte lysosomes: interactions with infectious agents, phagosomes, and experimental perturbations in function. Annu Rev Microbiol (1977) 2.19
Conjunctival necrosis following the administration of subconjunctival corticosteroid. Ophthalmic Surg Lasers (1998) 1.98
Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect Immun (1974) 1.91
Corneal dystrophies. II. Endothelial dystrophies. Surv Ophthalmol (1979) 1.90
Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide. J Immunol (1967) 1.87
Clear corneal wound infection after phacoemulsification. Arch Ophthalmol (2001) 1.83
Anterior chamber cleavage syndrome. A stepladder classification. Surv Ophthalmol (1975) 1.78
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome. Am J Ophthalmol (2001) 1.74
Corneal ulcers associated with contact lens wear. Arch Ophthalmol (1984) 1.70
Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J Immunol (1988) 1.70
Tarsorrhaphy: clinical experience from a cornea practice. Cornea (2001) 1.66
Corneal dystrophies. I. Dystrophies of the epithelium, Bowman's layer and stroma. Surv Ophthalmol (1978) 1.65
Acute hydrops in the corneal ectasias: associated factors and outcomes. Trans Am Ophthalmol Soc (1999) 1.64
Conjunctival autograft for pterygium surgery: how well does it prevent recurrence? Ophthalmic Surg Lasers (1997) 1.61
Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect Immun (1974) 1.60
A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study. Arch Dermatol (2000) 1.60
Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology (1997) 1.59
Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J (1994) 1.56
Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. Ophthalmology (1988) 1.55
The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro-indicators of virulence. J Gen Microbiol (1978) 1.55
Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields. Eye (Lond) (1996) 1.54
Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties. Biochim Biophys Acta (1970) 1.53
Initial treatment of microbial keratitis. CLAO J (1996) 1.50
Use of routine antibiotic sensitivity testing for the management of corneal ulcers. Arch Ophthalmol (1997) 1.50
Corneal transplantation in children with Peters anomaly and mesenchymal dysgenesis. Multicenter Pediatric Keratoplasty Study. Ophthalmology (1997) 1.50
Disorders of the corneal epithelium. A clinicopathologic study of dot, geographic, and fingerprint patterns. Arch Ophthalmol (1974) 1.49
Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults. J Hum Hypertens (2012) 1.49
Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. II. Structural studies. Biochim Biophys Acta (1970) 1.48
Immunofluorescence studies of reactions at the Cryptococcal capsule. J Infect Dis (1968) 1.47
Stability of refraction during four years after radial keratotomy in the prospective evaluation of radial keratotomy study. Am J Ophthalmol (1991) 1.45
Protein conjugates of polysaccharide from Cryptococcus neoforman s. J Immunol (1967) 1.44
Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology (1999) 1.43
Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol (2006) 1.42
Corneal transplantation in Maroteaux-Lamy syndrome. Arch Ophthalmol (1997) 1.42
Trehalose-containing lipooligosaccharides. A new class of species-specific antigens from Mycobacterium. J Biol Chem (1983) 1.41
Management of small corneal infiltrates in contact lens wearers. Arch Ophthalmol (2000) 1.39
Corneal ulcers and the use of topical fluoroquinolones. CLAO J (1999) 1.39
Disposable contact lenses: the jury is out. CLAO J (1989) 1.38
Reactivation of herpetic keratitis by epinephrine in rabbit. Arch Ophthalmol (1966) 1.38
Long-term results after penetrating keratoplasty for Fuchs' endothelial dystrophy. Arch Ophthalmol (1996) 1.38
Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol (1999) 1.35
Chalazion-induced hyperopia as a cause of decreased vision. Ophthalmic Surg Lasers (1997) 1.34
Dystrophic changes in the anterior cornea. Arch Ophthalmol (1972) 1.34
Results of the Prospective Evaluation of Radial Keratotomy (PERK) Study five years after surgery. The Perk Study Group. Ophthalmology (1991) 1.33
Synergistic action of cord factor and mycobacterial sulfatides on mitochondria. Infect Immun (1974) 1.31
Diagnosis and management of Acanthamoeba keratitis. Am J Ophthalmol (1985) 1.31
Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology (1997) 1.30
Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol (1987) 1.30
Corneal complications of topical anesthetic abuse. Can J Ophthalmol (1970) 1.28
Trends in contact lens-associated corneal ulcers. Cornea (1996) 1.27
Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents. Biochemistry (1971) 1.27
Cornea and sclera. Arch Ophthalmol (1972) 1.27
Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology (1999) 1.26
Expression of peroxidase-dependent iodination by macrophages ingesting neutrophil debris. J Reticuloendothel Soc (1980) 1.26
Immunoreactive substances of mycobacteria. Am Rev Respir Dis (1982) 1.26
Ultrasound biomicroscopy as a tool for detecting and localizing occult foreign bodies after ocular trauma. Ophthalmology (1999) 1.26
Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect Immun (1988) 1.25
Familial occurrence of dot (microcystic), map, fingerprint dystrophy of the cornea. Invest Ophthalmol (1975) 1.24
Differential and sequential delivery of fluorescent lysosomal probes into phagosomes in mouse peritoneal macrophages. J Cell Biol (1987) 1.24
Schirmer's test. A closer look. Arch Ophthalmol (1983) 1.23
Diphtheroids as ocular pathogens. Am J Ophthalmol (1989) 1.22
Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-I). Biochemistry (1976) 1.20